"The acquistion of BASF's finished dosage manufacturing facility in the US will enable us to strengthen our supply chain for North America and provide a strong platform for pursuing additional growth opportunities," said Satish Reddy, managing director and chief operating officer, Dr Reddy's Laboratories.

The acquisition will include relevant business, customer contracts and trademarks as well as the manufacturing facility and assets of BASF at Shreverport. It also includes a tolling and supply agreement. BASF is world's leading chemical company.